Yanxin YU
6Patents
1h-index
20Co-inventors
40Inventor score
Filing activity: Apr 8, 2018 → May 8, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11117899B2 | [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor | Human Necessities | 2 | Active |
| US12030897B2 | Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof | Human Necessities | 0 | Active |
| US11466024B2 | Bicylic compound acting as an inhibitor | Chemistry; Metallurgy | 0 | Active |
| US11649239B2 | Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1) | Chemistry; Metallurgy | 0 | Active |
| US11377444B2 | Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11066411B2 | [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.